Membrane Oxygenator Market (By Type: Hollow Fibre Membrane Oxygenator and Flat Sheet Membrane Oxygenator; By Application: Respiratory, Cardiac, and Extra-Corporeal Cardiopulmonary Resuscitation (ECPR); By Region: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) Industry Size, Share, Growth, Trends 2026 to 2035.
The global membrane oxygenator market was valued at USD 364.32 million in 2025 and is projected to reach approximately USD 512.94 million by 2035, growing at a CAGR of 3.48%. The market growth is primarily driven by the rising prevalence of cardiovascular diseases, increasing adoption of extracorporeal membrane oxygenation (ECMO) procedures, and continuous technological advancements in oxygenator design.
| Reports Attributes | Statistics |
| Market Size in 2025 | USD 364.32 Million |
| Market Size in 2026 | USD 377.07 Million |
| Market Size in 2032 | USD 463.52 Million |
| Market Size by 2035 | USD 512.94 Million |
| CAGR 2026 to 2035 | 3.48% |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
The membrane oxygenator market is attaining significant popularity due to the rising cardiovascular and respiratory disease burden, which creates a massive demand for such medical devices. WHO also states that the prevalence of CVD is around 80% in low and middle-income countries due to limited healthcare service options. This is mainly due to the higher treatment costs and poor healthcare infrastructure in these regions, which may hinder the growth pace of the market. However, the governments in the developing economies are trying to invest more in their healthcare infrastructure to enable services to their citizens. They are also targeting domestic manufacturing of such medical devices to increase their affordability in their own regions.
The emergence of technologies like Artificial Intelligence (AI) and Machine Learning (ML) is playing a transformative role in the membrane oxygenator market due to their algorithms that track the oxygen levels, blood flow, and other parameters during diagnosis. Moreover, they are also helping in personalizing treatment options based on past data for more accurate outcomes.
| Segments | Shares (%) |
| North America | 40% |
| Europe | 30% |
| Asia Pacific | 20% |
| LAMEA | 10% |
| Segments | Shares (%) |
| Hollow Fibre Membrane Oxygenator | 65% |
| Flat Sheet Membrane Oxygenator | 35% |
| Segments | Shares (%) |
| Respiratory | 50% |
| Cardiac | 40% |
| Extra | 10% |
Published by Ajit Bansod
